Latest news with #Jiva
Cision Canada
7 days ago
- Business
- Cision Canada
Jiva Technologies First Purchase Order of LIV3's SugarShield Supplement Is Ready to Ship from Best Formulations and Will Begin Shipping Direct to Consumers by June 10, 2025
VANCOUVER, BC, June 5, 2025 /CNW/ -- Jiva Technologies (CSE: JIVA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("JIVA" or the "Company"), a leader in building niche online wellness communities and creating immersive physical environments, is pleased to announce that the first commercial production run of LIV3's SugarShield supplement is ready to ship from Best Formulations, a Sirio Group company. Fulfillment to consumers will begin on June 10, 2025, with pre-sale orders placed since the website's January launch transitioning to active shipping and standard orders opening thereafter. Best Formulations, a Sirio Group company renowned for producing some of the most recognized supplements in the United States, brings unparalleled expertise and quality assurance to this project. LIV3's SugarShield capsules feature a liposomal delivery system designed to enhance nutrient absorption and bioavailability, with benefits expected to be felt within as little as two weeks. Jiva believes that the e-commerce supplements category continues to expand rapidly, driven by increasing consumer demand for functional, science-backed products that support targeted wellness goals—from metabolic health to cognitive performance. The segment has seen significant growth as consumers prioritize convenience and transparency, with direct-to-consumer brands leading the charge. Lorne Rapkin, CEO of Jiva Technologies, commented: " is without question one of my favorite websites we've built at Jiva. I've been closely following the surge of new supplement brands launching GLP-1-inspired formulations and other wellness-forward solutions, and it's clear the world is ready for products that support better health outcomes in accessible ways. I believe that supplements are the fastest growing category in e-commerce right now, and partnering with Chris Mearns to launch SugarShield and oversee the entire digital strategy is a critical part of our vision to make wellness more attainable for everyone. I genuinely cannot wait for people to hold these jars in their hands and experience the results for themselves." This marks another milestone in Jiva's expanding portfolio of wellness-focused ventures, as the Company continues to leverage its digital expertise and consumer insights to build brands that connect with today's health-conscious audience. For more information about LIV3 or SugarShield, please visit About JIVA Technologies JIVA Technologies is dedicated to building niche online wellness communities and creating immersive physical environments. With a proven track record in e-commerce marketplaces, bolstered by expert UI/UX design and SEO, JIVA now focuses on joint ventures to support wellness brands in developing their online presence. The company owns and operates Bloombox Club, an online plant delivery marketplace serving the United States, Germany, the United Kingdom, Austria, the Republic of Ireland, France, Spain, and Italy, as well as The Locavore Bar and Grill, a vibrant dining and gathering destination in Squamish, BC. Recently, JIVA became a shareholder in VEG House, a leader in the plant-based space, through a share exchange agreement. Committed to e-commerce, marketing, and wellness, JIVA's mission is to cultivate online communities of like-minded consumers through education and collaboration. The company is actively pursuing joint ventures, such as the recently announced partnership with LIV3 for SugarShield, to empower wellness brands online by building their websites and managing all digital marketing. About LIV3 LIV3 is dedicated to improving metabolic health by addressing the detrimental effects of fructose through its flagship product, SugarShield. Originally introduced through where the product received overwhelmingly positive feedback for its efficacy, SugarShield features Luteolin, a powerful compound that blocks fructokinase. SugarShield has the potential to reduce cravings, boost energy, and support weight management by preventing fructose metabolism. This innovative approach allows individuals to experience the benefits of a sugar-free lifestyle without making drastic dietary changes. Backed by research, LIV3's solution targets the suspected root cause of metabolic dysfunction and offers a natural, effective way to improve overall health and wellness. About Best Formulations (a Sirio Company) Best Formulations, a Sirio Company, is a leading U.S.-based contract manufacturer specializing in high-quality dietary supplements, over-the-counter drugs, and functional foods. As part of the global Sirio Group—a renowned leader in the nutraceutical industry—Best Formulations combines international expertise with state-of-the-art manufacturing facilities in the United States. Committed to excellence and stringent quality control, the company adheres to strict U.S. regulatory standards and Good Manufacturing Practices (GMP), ensuring that products like SugarShield are manufactured to the highest quality. With over 35 years of industry experience, Best Formulations is dedicated to being a trusted partner in bringing innovative health products to market both domestically and internationally. Contact Lorne Rapkin Chief Executive Officer (416) 419-1415 Forward-looking Information This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may," "will," "expect," "likely", "should," "would," "plan," "anticipate," "intend," "potential," "proposed," "estimate," "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the availability of Future Farm products, JIVA promotional events and the business and strategic plans of the Company. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: receiving sufficient demand for the Offering; the Company's ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; the conflict in eastern Europe; having a limited operating history; the ability of the Company to access capital to meet future financing needs; the Company's reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions. Additional risk factors can also be found in the Company's continuous disclosure documents, which have been filed on SEDAR and can be accessed at Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained applicable herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by law.
The Sun
25-04-2025
- Politics
- The Sun
Hearing of prosecution's review bid vacated
PUTRAJAYA: The Federal Court here today vacated the hearing of the prosecution's review application challenging the top court's earlier 2-1 majority ruling that it (the Federal Court) has the jurisdiction to review death sentences that had been imposed on four prisoners whose sentences have been commuted by the Pardons Boards. Lawyer Datuk representing two of the four prisoners, told the media that the hearing did not proceed today to allow the parties to explore the possibility of applying the Federal Court's ruling to 123 other prisoners who are in the same situation as the four. He said a case management has been fixed for June 3 for parties to update the court on any development. On Aug 27, last year, the Federal Court ruled in a split decision that it had the jurisdiction under the Revision of Sentence of Death and Imprisonment for Natural Life (Temporary Jurisdiction of The Federal Court) Act 2023 (Act 847), to review the death sentences that were imposed on the four for drug trafficking offences. The majority decision, made by Justices Tan Sri Harmindar Singh Dhaliwal and Datuk Hanipah Farikullah, held that the 30-year prison sentences imposed on the four prisoners should take effect from the date of their arrest, and not from the date their pardons were granted. Justice Datuk Nordin Hassan dissented. Following this, the prosecution filed a review application under Rule 137 of the Rules of the Federal Court 1995, contending that the judges who decided the majority ruling had acted beyond their jurisdiction. Meanwhile, lawyer Abdul Rashid Ismail, representing Zambian national Mailesi Phiri, told the media that the jail terms of 123 other prisoners were calculated from the date of their respective Pardons Board's clemency decision, rather than from the date of their arrest. 'This means that the time they spent in custody prior to the granting of the pardon has not been taken into account, resulting in longer prison terms beyond the 30-year jail term set under Section 39B (2) of the Dangerous Drugs Act 1952,' he explained. The Federal Court had in August last year allowed the four individuals – G. Jiva, 55; P. Balakrishnan, 48; Thai national Phrueksa Thaemchim, 41; and Phiri, 47 – to commence their 30-year jail terms from the date of their arrest. Sivananthan is representing Jiva and Balakrishnan, while lawyer K. Simon Murali is representing Phrueksa. Deputy Public Prosecutors Datin Asmah Musa, Tetralina Ahmed Fauzi, Ng Siew Wee, and Solehah Noratikah Ismail are appearing for the prosecution.
The Sun
25-04-2025
- Politics
- The Sun
Federal Court delays hearing on death sentence review case
PUTRAJAYA: The Federal Court here today vacated the hearing of the prosecution's review application challenging the top court's earlier 2-1 majority ruling that it (the Federal Court) has the jurisdiction to review death sentences that had been imposed on four prisoners whose sentences have been commuted by the Pardons Boards. Lawyer Datuk representing two of the four prisoners, told the media that the hearing did not proceed today to allow the parties to explore the possibility of applying the Federal Court's ruling to 123 other prisoners who are in the same situation as the four. He said a case management has been fixed for June 3 for parties to update the court on any development. On Aug 27, last year, the Federal Court ruled in a split decision that it had the jurisdiction under the Revision of Sentence of Death and Imprisonment for Natural Life (Temporary Jurisdiction of The Federal Court) Act 2023 (Act 847), to review the death sentences that were imposed on the four for drug trafficking offences. The majority decision, made by Justices Tan Sri Harmindar Singh Dhaliwal and Datuk Hanipah Farikullah, held that the 30-year prison sentences imposed on the four prisoners should take effect from the date of their arrest, and not from the date their pardons were granted. Justice Datuk Nordin Hassan dissented. Following this, the prosecution filed a review application under Rule 137 of the Rules of the Federal Court 1995, contending that the judges who decided the majority ruling had acted beyond their jurisdiction. Meanwhile, lawyer Abdul Rashid Ismail, representing Zambian national Mailesi Phiri, told the media that the jail terms of 123 other prisoners were calculated from the date of their respective Pardons Board's clemency decision, rather than from the date of their arrest. 'This means that the time they spent in custody prior to the granting of the pardon has not been taken into account, resulting in longer prison terms beyond the 30-year jail term set under Section 39B (2) of the Dangerous Drugs Act 1952,' he explained. The Federal Court had in August last year allowed the four individuals – G. Jiva, 55; P. Balakrishnan, 48; Thai national Phrueksa Thaemchim, 41; and Phiri, 47 – to commence their 30-year jail terms from the date of their arrest. Sivananthan is representing Jiva and Balakrishnan, while lawyer K. Simon Murali is representing Phrueksa. Deputy Public Prosecutors Datin Asmah Musa, Tetralina Ahmed Fauzi, Ng Siew Wee, and Solehah Noratikah Ismail are appearing for the prosecution.
Yahoo
17-04-2025
- Business
- Yahoo
JK Tech and Inveniam Forge Strategic Partnership to Transform Alternative Investments with Blockchain and AI
NEW DELHI, April 17, 2025 /PRNewswire/ -- JK Tech, a global leader in AI-powered digital transformation solutions, and Inveniam, a pioneering data integrity platform for private market assets, today announced a strategic partnership to revolutionize alternative investments through blockchain and AI technology. The collaboration will develop Inveniam's next-generation platform for alternative investments, integrating JK Tech's IP to enhance structured data capabilities while leveraging JK Tech's advanced engineering expertise with Inveniam's private market data operations orchestration. This partnership will set new standards for efficiency and trust in private market investments, addressing the growing demand for real-time data processing in digital markets. JK Tech will integrate its Generative AI solution, JIVA, into the Inveniam platform, empowering institutional investors, asset managers, and financial firms with enhanced automation, data-driven insights, and intelligent decision-making capabilities. Both companies are making significant joint investments to expand across key markets in the US, Abu Dhabi, and India. "This partnership with Inveniam exemplifies JK Tech's commitment to driving innovation in financial services," stated Sameer Nagpal, President & CEO of JK Tech. "By integrating JIVA with Inveniam's platform, we are enabling AI-driven automation and data integrity at an unprecedented scale, fundamentally transforming how alternative investments are managed and valued." Patrick O'Meara, Chairman & CEO of Inveniam, added, "At Inveniam, we are dedicated to reshaping private markets at the intersection of blockchain and AI. JK Tech's world-class Jiva solution and their expertise in digital engineering significantly strengthens our ability to deliver a transparent, scalable, and automated future for alternative investments." The partnership will deliver AI-driven decision-making through advanced analytics, enhanced data integrity via blockchain, scalable global expansion, and automated investment workflows, empowering financial institutions with greater accuracy in managing alternative investments. About JK Tech JK Tech is a Gen AI-focused data services organization empowering enterprises in Retail, CPG, and Financial Services through its strategic partnership with Google Cloud and flagship platform solution, JIVA. Visit About Inveniam Inveniam is a data operating system for private market assets, bringing access, transparency, and trust to asset performance data. The company is building the foundation for scalable AI integration, data marketplaces in private finance, and the systematic trading of private market assets. View original content to download multimedia: SOURCE Inveniam Capital Partners Sign in to access your portfolio
